A successful treatment center experience is enabled by strong launch readiness, efficient site activation, and reliable patient access. InspiroGene is designed to make that experience simple, consistent, and scalable so approved therapies translate seamlessly into patient care.
InspiroGene leverages long-standing McKesson relationships to give manufacturers immediate access to a broad national network of advanced treatment centers. These trusted partnerships enable faster uptake across both established and emerging CGT programs by:
InspiroGene supports a variety of treatment centers, from large health systems and academic hospitals to community hospitals and specialized clinics. Our model is purpose-built to work across therapeutic areas and care settings, allowing manufacturers to confidently scale networks without redesigning the treatment center experience as programs grow.
Treatment centers are supported through a dedicated InspiroGene engagement model purpose‑built for cell and gene therapy. This model brings continuity and specialized CGT expertise to the treatment center, helping sites operate more smoothly and supporting reliable, scalable execution.
We intentionally designed the treatment center experience to be straightforward and consistent, minimizing administrative burden for sites regardless of therapy, manufacturer, or channel.
Our experienced CGT team provides proactive, high-touch support to resolve issues quickly, reduce administrative burden, and keep treatment centers focused on patient care rather than process complexity.
InspiroLink is a purpose-built ordering platform for cell and gene therapy, designed to address the unique operational, financial, and coordination demands of CGT.
Not actual patients.
